Glionyx-MV 1mg/500mg/0.2mg Tablet
Marketer
Iynx Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glionyx-MV 1mg/500mg/0.2mg Tablet
Diabex-Trio (1mg/500mg/0.2mg) tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes to manage blood glucose. Consistent daily dosing, ideally at the same time with food, maximizes therapeutic effect. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. Diabex-Trio is only one component of a comprehensive diabetes management plan; a healthy diet, regular physical activity, and weight management, as directed by your doctor, are essential. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry a quick-acting glucose source (e.g., sugary snacks or juice), and avoid alcohol, which increases hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women should consult their doctor. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Glionyx-MV 1mg/500mg/0.2mg Tablet
No text provided to rephrase.
Uses of Glionyx-MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glionyx-MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Glionyx-MV 1mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Glionyx-MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glionyx-MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Glionyx-MV 1mg/500mg/0.2mg Tablet on an empty stomach.
How Glionyx-MV 1mg/500mg/0.2mg Tablet works:
Each Glionyx-MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glionyx-MV 1mg/500mg/0.2mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glionyx-MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Glionyx-MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glionyx-MV 1mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its use is discouraged in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glionyx-MV 1mg/500mg/0.2mg tablets cautiously, as dosage modification may be necessary. Individuals with mild to moderate hepatic dysfunction typically begin with a reduced Glionyx-MV 1mg/500mg/0.2mg tablet dose; however, its administration is contraindicated in those with severe liver disease. Medical advice is recommended.
What if you forget to take Glionyx-MV 1mg/500mg/0.2mg Tablet :
Should you forget a Glionyx-MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glionyx-MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently